Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells.
D000477:Alkylating Agents / Q000494:pharmacology*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects*; D000941:Antigens; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D004912:Erythrocytes; D006087:Graft vs Host Reaction / Q000187:drug effects; D006462:Hemolytic Plaque Technique; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D051379:Mice; D008809:Mice, Inbred C3H; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology*; D012756:Sheep; D013154:Spleen / Q000166:cytology / Q000276:immunology*
D000477:Alkylating Agents; D000941:Antigens; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds